October 1st, 2026CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug CostsCMS finalized the mandatory GLOBE Model, tying Part B drug rebates to international prices in areas covering 25% of beneficiaries from Jan. 1, 2027.Read more
October 1st, 2026Specialty Pharmacy Faces Gaps in Payment, Data, and Patient TrustAt inSPire2026, experts highlighted gaps in specialty therapy payment, 340B data, clinical trials, and AI-driven care. Read more
October 1st, 2026FDA Expands Mavacamten Label to Include Children With oHCMThe approval is based on findings from the phase 3 SCOUT-HCM trial. Read more
October 1st, 2026Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2DSurvodutide achieved up to 13.1% weight loss vs 3.1% with placebo at 76 weeks in adults with obesity and T2D in the phase 3 SYNCHRONIZE-2 trial.Read more
September 30th, 2026Proposed Medicare Rate Cuts Draw AASM Opposition Ahead of Final RuleAASM urges CMS to reject proposed 2027 Medicare conversion factor cuts of 1.19% to 1.68% and revise sleep testing and remote monitoring policies.Read more
September 30th, 2026Sarcoma-to-Heart Case Highlights Need for Multidisciplinary CareA rare case of soft-tissue sarcoma spreading to the heart shows how multimodal imaging guided diagnosis and care in a 36-year-old man.Read more
September 30th, 2026Routine Blood Test Ratio Linked to Higher Mortality Risk in Adults With CKDA higher ratio of red blood cell distribution width to albumin was tied to greater all-cause, cardiovascular, and cancer mortality in adults with CKD.Read more
September 30th, 2026Sleep-Disordered Breathing Linked to MASLD, but Evidence Certainty Is LowA meta-analysis of 22 studies found steatotic liver disease in about three-quarters of patients with sleep-disordered breathing.Read more